Opinion: A serious issue with the standardization of the adenovirus-based COVID-19 vaccines?
Arch Toxicol
.
2021 Sep;95(9):3137-3139.
doi: 10.1007/s00204-021-03126-9.
Epub 2021 Aug 6.
Author
Michael Arand
1
Affiliation
1
Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland. arand@pharma.uzh.ch.
PMID:
34357440
PMCID:
PMC8342650
DOI:
10.1007/s00204-021-03126-9
No abstract available
Publication types
Letter
MeSH terms
Adenoviridae / genetics*
Adenoviridae / immunology
Animals
COVID-19 / prevention & control*
COVID-19 Vaccines / standards*
Genetic Vectors
HEK293 Cells
Humans
Mice
Mice, Inbred BALB C
SARS-CoV-2 / immunology*
Substances
COVID-19 Vaccines